Is weight gain more likely with a hormonal intrauterine device (IUD) compared to combined oral contraceptive pills?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Weight Gain: Hormonal IUD vs Oral Contraceptives

Based on the available evidence, combined oral contraceptives (COCs) are associated with greater weight gain compared to hormonal IUDs (levonorgestrel-IUD). The most recent high-quality randomized trial directly comparing these methods found that women using the levonorgestrel implant (similar progestin-only mechanism to LNG-IUD) gained significantly less weight than those using combined oral contraceptives 1.

Evidence from Direct Comparative Studies

The ECHO trial, a large multicenter randomized controlled trial, provides the strongest evidence on this question. Over 12-18 months of follow-up:

  • Levonorgestrel implant users gained a mean of 2.4 kg (SD = 5.9)
  • This was 0.87 kg less than copper IUD users (mean 1.5 kg gain, p < 0.001)
  • While not directly comparing oral contraceptives, this demonstrates that progestin-only methods like the LNG implant (which shares the same hormone as LNG-IUDs) cause modest weight gain 1

Weight Gain Patterns by Method

Recent cross-sectional data from 2025 confirms that COC users report significantly higher mean weight gain compared to users of other hormonal methods 2. Additionally, women with overweight (aOR 1.76, p = 0.048) and obesity (aOR 1.68, p = 0.033) have higher odds of discontinuing COCs specifically due to self-reported weight gain 3.

Guideline Perspective on Weight Concerns

The 2024 CDC guidelines note that weight measurement is not needed to determine medical eligibility for any contraceptive method, but measuring baseline weight may be helpful for discussing concerns about changes and whether they relate to the contraceptive method 4. Importantly, the 2012 French Society of Endocrinology guidelines state that "at the population scale, there is no evidence that estrogen-progestin contraception causes weight gain" 5, though this appears contradicted by more recent trial data.

Clinical Implications

Key Points for Counseling:

  • Hormonal IUDs (LNG-IUD) are associated with less weight gain than combined oral contraceptives
  • Weight gain with hormonal contraception is real but modest (typically 2-3.5 kg over 12-18 months)
  • The copper IUD (non-hormonal) is associated with the least weight change if this is a primary concern
  • Women with higher baseline BMI are more likely to perceive and report weight gain as problematic

Common Pitfall to Avoid:

Do not dismiss patient concerns about weight gain as purely psychological. Recent high-quality evidence demonstrates measurable differences between methods, and these concerns significantly impact contraceptive continuation rates, which directly affects pregnancy prevention and quality of life.

For patients prioritizing minimal weight gain: recommend the copper IUD first, followed by the LNG-IUD as a hormonal alternative, with COCs being the least favorable option from a weight gain perspective 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.